Gail Nunlee-Bland

Dr. Gail Nunlee-Bland

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
GNGail Nunlee-Bland
Gail Nunlee-Bland
SRS.R. Rana
S.R. Rana
PHP.E. Houston-Yu
P.E. Houston-Yu
WOW. Odonkor
W. Odonkor
Growth disorders are common in children with sickle cell disease (SCD). The etiology for growth disturbances in this population appears to be multifactorial. Recent evidence suggests abnormalities in the growth hormone (GH)/insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) axis may play a role. To measure GH levels through provocative stimulation in a group of patients with SCD with growth failure, and to evaluate response to treatment. Growth records were reviewed of 79 children with sickle cell hemoglobinopathies to identify children with growth failure. GH levels were measured in patients with SCD with and without growth failure using arginine and L-Dopa as provocative stimulation tests. Treatment with GH was offered to GH-deficient children with SCD and these patients were followed longitudinally over 5 years. Of the 79 patients, 13 (16.5%, all SS) had heights less than -2 SD below the mean or a growth velocity < -2 SD below the mean for age. Seven of the 13 children with growth failure participated in this study. Five patients received GH for 3 or more years and demonstrated significant improvement in their height SDS. One of the two who declined treatment was lost to follow-up and the other had significant worsening of height SDS score. GH deficiency may be associated with growth failure in some patients with SCD. These patients may benefit from treatment with GH.

ZNZarish Noreen
Zarish Noreen
JDJessica DeJesus
Jessica DeJesus
ABAttya Bhatti
Attya Bhatti
CLChristopher Loffredo
Christopher Loffredo
PJPeter John
Peter John
Somiranjan GhoshSomiranjan Ghosh
Somiranjan Ghosh
The epidemic of type 2 diabetes mellitus (T2DM) and the possibility of it contributing to the risk of Alzheimer’s disease (AD) have become important health concerns worldwide and in Pakistan, where the co-occurrence of T2DM and AD is becoming more frequent. To gain insights on this phenomenon, a cross-sectional study was initiated. We recruited and interviewed 820 research participants from four cities in Pakistan: 250 controls, 450 T2DM, 100 AD, and 20 with both diseases. Significant differences between groups were observed for age (p < 0.0001), urban vs. rural locality (p = 0.0472) and residing near industrial areas. The average HbA1c (%) level was 10.68 ± 2.34 in the T2DM group, and females had a lower level than males (p = 0.003). In the AD group, significant relationships existed between education and family history. Overall, the results suggest that T2DM and AD were associated with both socio-demographic and environmental factors in Pakistani participants. Detailed molecular investigations are underway in our laboratory to decipher the differential genetic pathways of the two diseases to address their increasing prevalence in this developing nation.

ZNZarish Noreen
Zarish Noreen
CLChristopher Loffredo
Christopher Loffredo
ABAttya Bhatti
Attya Bhatti
JSJyothirmai Simhadri
Jyothirmai Simhadri
GNGail Nunlee-Bland
Gail Nunlee-Bland
Somiranjan GhoshSomiranjan Ghosh
Somiranjan Ghosh
The epidemic of type 2 diabetes mellitus (T2DM) is an important global health concern. Our earlier epidemiological investigation in Pakistan prompted us to conduct a molecular investigation to decipher the differential genetic pathways of this health condition in relation to non-diabetic controls. Our microarray studies of global gene expression were conducted on the Affymetrix platform using Human Genome U133 Plus 2.0 Array along with Ingenuity Pathway Analysis (IPA) to associate the affected genes with their canonical pathways. High-throughput qRT-PCR TaqMan Low Density Array (TLDA) was performed to validate the selected differentially expressed genes of our interest, viz., ARNT, LEPR, MYC, RRAD, CYP2D6, TP53, APOC1, APOC2, CYP1B1, SLC2A13, and SLC33A1 using a small population validation sample (n = 15 cases and their corresponding matched controls). Overall, our small pilot study revealed a discrete gene expression profile in cases compared to controls. The disease pathways included: Insulin Receptor Signaling, Type II Diabetes Mellitus Signaling, Apoptosis Signaling, Aryl Hydrocarbon Receptor Signaling, p53 Signaling, Mitochondrial Dysfunction, Chronic Myeloid Leukemia Signaling, Parkinson’s Signaling, Molecular Mechanism of Cancer, and Cell Cycle G1/S Checkpoint Regulation, GABA Receptor Signaling, Neuroinflammation Signaling Pathway, Dopamine Receptor Signaling, Sirtuin Signaling Pathway, Oxidative Phosphorylation, LXR/RXR Activation, and Mitochondrial Dysfunction, strongly consistent with the evidence from epidemiological studies. These gene fingerprints could lead to the development of biomarkers for the identification of subgroups at high risk for future disease well ahead of time, before the actual disease becomes visible.

Verified
Journal Article
Open access
PDF file
TMTanmoy Mondal
Tanmoy Mondal
Coleman I. SmithColeman I. Smith
Coleman I. Smith
CLChristopher Loffredo
Christopher Loffredo
RQRuth Quartey
Ruth Quartey
GMGemeyel Moses
Gemeyel Moses
Somiranjan GhoshSomiranjan Ghosh
Somiranjan Ghosh
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is becoming the most common chronic liver disease worldwide and is of concern among African Americans (AA) in the United States. This pilot study evaluated the differential gene expressions and identified the signature genes in the disease pathways of AA individuals with MASLD. Blood samples were obtained from MASLD patients (n = 23) and non-MASLD controls (n = 24) along with their sociodemographic and medical details. Whole-blood transcriptomic analysis was carried out using Affymetrix Clarion-S Assay. A validation study was performed utilizing TaqMan Arrays coupled with Ingenuity Pathway Analysis (IPA) to identify the major disease pathways. Out of 21,448 genes in total, 535 genes (2.5%) were significantly (p < 0.05) and differentially expressed when we compared the cases and controls. A significant overlap in the predominant differentially expressed genes and pathways identified in previous studies using hepatic tissue was observed. Of note, TGFB1 and E2F1 genes were upregulated, and HMBS was downregulated significantly. Hepatic fibrosis signaling is the top canonical pathway, and its corresponding biofunction contributes to the development of hepatocellular carcinoma. The findings address the knowledge gaps regarding how signature genes and functional pathways can be detected in blood samples (‘liquid biopsy’) in AA MASLD patients, demonstrating the potential of the blood samples as an alternative non-invasive source of material for future studies.

11 December 2019 in The Open Biochemistry Journal
Verified
Journal Article
Open access
PDF file
IJIbrahim Jafri
Ibrahim Jafri
GAGhadi Alsharif
Ghadi Alsharif
GNGail Nunlee-Bland
Gail Nunlee-Bland
KGKanwal K. Gambhir
Kanwal K. Gambhir
Erythrocyte miRNA 144 and miRNA 451 as Cell Aging Biomarkers in African American Adults

8 September 2025 in Diabetes Spectrum
Verified
Journal Article
Closed access
GNGail Nunlee-Bland
Gail Nunlee-Bland
RMRochanda Mitchell
Rochanda Mitchell
IRInez V. Reeves
Inez V. Reeves
MYMichal A. Young
Michal A. Young
This study evaluated the use of real-time continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) with a glucose meter in pregnant patients with preexisting type 2 diabetes on insulin therapy. The use of CGM improved A1C and reduced infant morbidity and mortality compared with BGM alone.